Medicare expands kidney disease education, betting on prevention over dialysis

What it does

This bill expands Medicare and private insurance coverage of kidney disease education services starting January 2027. It allows qualified providers (doctors, nurses, dietitians, community health workers) to deliver education to patients with kidney disease, diabetes, hypertension, or related risk factors—in individual or group settings, with caregivers present, and via telehealth. Medicare will pay 100% of the cost. The bill also requires the HHS Secretary to establish a working group to measure effectiveness and create an assessment framework within two years.

Why we flagged it

The bill's core function is to expand Medicare and private insurance coverage of kidney disease education as a preventive service. It is straightforward public health legislation with no hidden mechanisms or narrow carve-outs.

What the text implies

• The bill grants the HHS Secretary broad discretion to determine 'appropriate' session numbers, screening tests, and assessment methodologies, potentially allowing future restrictions on access if political priorities shift.
• Telehealth expansion may increase access for rural patients but could also reduce in-person care relationships and clinical oversight in underserved areas.
• The working group and assessment framework (due within 2 years) may become a mechanism to justify future coverage limitations if outcomes data is interpreted narrowly.

Who it affects

Ordinary people with kidney disease, diabetes, and hypertension gain access to preventive education services at no out-of-pocket cost under Medicare and private insurance, potentially slowing disease progression and reducing costly dialysis/transplant needs. The expansion is broad-based (not limited to a narrow population) and includes caregiver support and telehealth access, improving reach to rural and underserved patients.

Who stands to gain

• dialysis providers (reduced patient volume if education slows progression)
• transplant centers (potential increase in transplant-ready patients)
• health technology vendors (telehealth platforms, assessment tools)
• community health organizations (employment of community health workers)

Named in the bill

Medicare, HHS Secretary, Centers for Medicare & Medicaid Services (CMS), qualified entities (kidney disease education providers), private health insurers, dialysis providers, transplant centers, community health workers, registered dietitians, clinical social workers

Where it stands

4 cosponsors: 2 Democrats, 2 Republicans.

• Jun 29, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jun 29, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

4 lobbying clients named this bill on 4 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $310,000 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 72% of bills with at least one filing.

Suzan DelBene, the sponsor, reported $1,605,299 in PAC receipts in the 2026 cycle.

• Travere Therapeutics — $140,000 on 1 filing
• National Kidney Foundation — $80,000 on 1 filing
• American Society of Nephrology — $60,000 on 1 filing
• National Kidney Foundation — $30,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.